Short-term supplementation with a specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects

Background and Objectives: Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The...

Full description

Saved in:
Bibliographic Details
Published inInternational Journal of Obesity Vol. 38; no. 5; pp. 698 - 706
Main Authors Most, J, Goossens, G H, Jocken, J W E, Blaak, E E
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.05.2014
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN0307-0565
1476-5497
1476-5497
DOI10.1038/ijo.2013.231

Cover

Loading…
Abstract Background and Objectives: Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects. Subjects and Methods: Eighteen healthy overweight volunteers (9 women, 9 men; age 35±2.5 years; body mass index 28.9±0.4 kg m −2 ) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg day −1 )+resveratrol (R, 200 mg day −1 ) and E+R+80 mg day −1 soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6 h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)). Results: Short-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45±0.24 vs 5.23±0.25 kJ min −1 , P =0.039), whereas both E+R (699±18 kJ 120 min −1 vs 676±20 kJ 120 min −1 , P =0.028) and E+R+S (704±18 kJ 120 min −1 vs 676±20 kJ 120 min −1 , P =0.014) increased 2–4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11±0.02 vs 0.06±0.02, P =0.059; E+R+S: 0.03±0.02, P =0.009). E+R+S significantly increased fasting plasma free fatty acid ( P =0.064) and glycerol ( P =0.021) concentrations compared with PLA. Conclusions: We demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation.
AbstractList Background and Objectives: Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects.Subjects and Methods: Eighteen healthy overweight volunteers (9 women, 9 men; age 35 plus or minus 2.5 years; body mass index 28.9 plus or minus 0.4 kg m super(-2)) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg day super(-1))+resve ratrol (R, 200 mg day super(-1)) and E+R+80 mg day super(-1) soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6 h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)). Results: Short-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45 plus or minus 0.24 vs 5.23 plus or minus 0.25 kJ min super(-1), P=0.039), whereas both E+R (699 plus or minus 18 kJ 120 min super(- 1) vs 676 plus or minus 20 kJ 120 min super(-1 ), P=0.028) and E+R+S (704 plus or minus 18 kJ 120 min super(- 1) vs 676 plus or minus 20 kJ 120 min super(-1 ), P=0.014) increased 2-4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11 plus or minus 0.02 vs 0.06 plus or minus 0.02, P=0.059; E+R+S: 0.03 plus or minus 0.02, P=0.009). E+R+S significantly increased fasting plasma free fatty acid (P=0.064) and glycerol (P=0.021) concentrations compared with PLA. Conclusions: We demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation.
BACKGROUND AND OBJECTIVES: Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects. SUBJECTS AND METHODS: Eighteen healthy overweight volunteers (9 women, 9 men; age 35 ± 2.5 years; body mass index 28.9 ± 0.4 kg [m.sup.-2]) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg[day.sup.-1]) + resveratrol (R, 200 mg[day.sup.-1]) and E + R + 80 mg[day.sup.-1] soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)). RESULTS: Short-term supplementation of E + R increased resting EE (E + R vs PLA: 5.45 ± 0.24 vs 5.23 ± 0.25 kJ [min.sup.-1], P = 0.039), whereas both E + R (699 ± 18 kJ 120 [min.sup.-1] vs 676 [+ or -] 20 kJ 120 [min.sup.-1], P = 0.028) and E + R + S (704 ± 18 kJ 120 [min.sup.-1] vs 676 ± 20 kJ 120 [min.sup.-1], P = 0.014) increased 2-4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E + R compared with PLA and E + R + S only in men (E + R vs PLA: 0.11 ± 0.02 vs 0.06± 0.02, P = 0.059; E + R + S: 0.03 [+ or -] 0.02, P = 0.009). E + R + S significantly increased fasting plasma free fatty acid (P = 0.064) and glycerol (P = 0.021) concentrations compared with PLA. CONCLUSIONS: We demonstrated for the first time that combined E + R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin -gallate combined with resveratrol may improve metabolic health and body weight regulation. International Journal of Obesity (2014) 38, 698-706; doi:10.1038/ijo.2013.231 Keywords: polyphenols; human substrate metabolism; resveratrol; epigallocatechin-gallate
Background and Objectives: Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects. Subjects and Methods: Eighteen healthy overweight volunteers (9 women, 9 men; age 35±2.5 years; body mass index 28.9±0.4 kg m −2 ) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg day −1 )+resveratrol (R, 200 mg day −1 ) and E+R+80 mg day −1 soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6 h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)). Results: Short-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45±0.24 vs 5.23±0.25 kJ min −1 , P =0.039), whereas both E+R (699±18 kJ 120 min −1 vs 676±20 kJ 120 min −1 , P =0.028) and E+R+S (704±18 kJ 120 min −1 vs 676±20 kJ 120 min −1 , P =0.014) increased 2–4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11±0.02 vs 0.06±0.02, P =0.059; E+R+S: 0.03±0.02, P =0.009). E+R+S significantly increased fasting plasma free fatty acid ( P =0.064) and glycerol ( P =0.021) concentrations compared with PLA. Conclusions: We demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation.
Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects. Eighteen healthy overweight volunteers (9 women, 9 men; age 35±2.5 years; body mass index 28.9±0.4 kg m(-2)) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg day(-1))+resveratrol (R, 200 mg day(-1)) and E+R+80 mg day(-1) soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6 h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)). Short-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45±0.24 vs 5.23±0.25 kJ min(-1), P=0.039), whereas both E+R (699±18 kJ 120 min(-1) vs 676±20 kJ 120 min(-1), P=0.028) and E+R+S (704±18 kJ 120 min(-1) vs 676±20 kJ 120 min(-1), P=0.014) increased 2-4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11±0.02 vs 0.06±0.02, P=0.059; E+R+S: 0.03±0.02, P=0.009). E+R+S significantly increased fasting plasma free fatty acid (P=0.064) and glycerol (P=0.021) concentrations compared with PLA. We demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation.
Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects. Eighteen healthy overweight volunteers (9 women, 9 men; age 35±2.5 years; body mass index 28.9±0.4kgm(-2)) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282mgday(-1))+resveratrol (R, 200mgday(-1)) and E+R+80mgday(-1) soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6h (high-fat-mixed meal (2.6MJ, 61.2 E% fat)). Short-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45±0.24 vs 5.23±0.25kJmin(-1), P=0.039), whereas both E+R (699±18kJ120min(-1) vs 676±20kJ120min(-1), P=0.028) and E+R+S (704±18kJ120min(-1) vs 676±20kJ120min(-1), P=0.014) increased 2-4h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11±0.02 vs 0.06±0.02, P=0.059; E+R+S: 0.03±0.02, P=0.009). E+R+S significantly increased fasting plasma free fatty acid (P=0.064) and glycerol (P=0.021) concentrations compared with PLA. We demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation.
International Journal of Obesity (2014) 38, 698-706; doi:10.1038/ijo.2013.231
Background and Objectives:Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects.Subjects and Methods:Eighteen healthy overweight volunteers (9 women, 9 men; age 35±2.5 years; body mass index 28.9±0.4 kg m−2) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg day−1)+resveratrol (R, 200 mg day−1) and E+R+80 mg day−1 soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6 h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)).Results:Short-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45±0.24 vs 5.23±0.25 kJ min−1, P=0.039), whereas both E+R (699±18 kJ 120 min−1 vs 676±20 kJ 120 min−1, P=0.028) and E+R+S (704±18 kJ 120 min−1 vs 676±20 kJ 120 min−1, P=0.014) increased 2–4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11±0.02 vs 0.06±0.02, P=0.059; E+R+S: 0.03±0.02, P=0.009). E+R+S significantly increased fasting plasma free fatty acid (P=0.064) and glycerol (P=0.021) concentrations compared with PLA.Conclusions:We demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation.
Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects.BACKGROUND AND OBJECTIVESImpaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that dietary polyphenols may modulate mitochondrial function, substrate metabolism and energy expenditure in humans. The present study investigated the effects of short-term supplementation of two combinations of polyphenols on energy expenditure (EE) and substrate metabolism in overweight subjects.Eighteen healthy overweight volunteers (9 women, 9 men; age 35±2.5 years; body mass index 28.9±0.4 kg m(-2)) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg day(-1))+resveratrol (R, 200 mg day(-1)) and E+R+80 mg day(-1) soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6 h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)).SUBJECTS AND METHODSEighteen healthy overweight volunteers (9 women, 9 men; age 35±2.5 years; body mass index 28.9±0.4 kg m(-2)) participated in a randomized, double-blind cross-over trial. Combinations of epigallocatechin-gallate (E, 282 mg day(-1))+resveratrol (R, 200 mg day(-1)) and E+R+80 mg day(-1) soy isoflavones (S) or placebo capsules (PLA) were supplemented twice daily for a period of 3 days. On day 3, circulating metabolite concentrations, EE and substrate oxidation (using indirect calorimetry) were measured during fasting and postprandial conditions for 6 h (high-fat-mixed meal (2.6 MJ, 61.2 E% fat)).Short-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45±0.24 vs 5.23±0.25 kJ min(-1), P=0.039), whereas both E+R (699±18 kJ 120 min(-1) vs 676±20 kJ 120 min(-1), P=0.028) and E+R+S (704±18 kJ 120 min(-1) vs 676±20 kJ 120 min(-1), P=0.014) increased 2-4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11±0.02 vs 0.06±0.02, P=0.059; E+R+S: 0.03±0.02, P=0.009). E+R+S significantly increased fasting plasma free fatty acid (P=0.064) and glycerol (P=0.021) concentrations compared with PLA.RESULTSShort-term supplementation of E+R increased resting EE (E+R vs PLA: 5.45±0.24 vs 5.23±0.25 kJ min(-1), P=0.039), whereas both E+R (699±18 kJ 120 min(-1) vs 676±20 kJ 120 min(-1), P=0.028) and E+R+S (704±18 kJ 120 min(-1) vs 676±20 kJ 120 min(-1), P=0.014) increased 2-4 h-postprandial EE compared with PLA. Metabolic flexibility, calculated as the postprandial increase to the highest respiratory quotient achieved, tended to be improved by E+R compared with PLA and E+R+S only in men (E+R vs PLA: 0.11±0.02 vs 0.06±0.02, P=0.059; E+R+S: 0.03±0.02, P=0.009). E+R+S significantly increased fasting plasma free fatty acid (P=0.064) and glycerol (P=0.021) concentrations compared with PLA.We demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation.CONCLUSIONSWe demonstrated for the first time that combined E+R supplementation for 3 days significantly increased fasting and postprandial EE, which was accompanied by improved metabolic flexibility in men but not in women. Addition of soy isoflavones partially reversed these effects possibly due to their higher lipolytic potential. The present findings may imply that long-term supplementation of these dosages of epigallocatechin-gallate combined with resveratrol may improve metabolic health and body weight regulation.
Audience Academic
Author Most, J
Blaak, E E
Jocken, J W E
Goossens, G H
Author_xml – sequence: 1
  givenname: J
  surname: Most
  fullname: Most, J
  email: jasper.most@maastrichtuniversity.nl
  organization: Department of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center+
– sequence: 2
  givenname: G H
  surname: Goossens
  fullname: Goossens, G H
  organization: Department of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center+
– sequence: 3
  givenname: J W E
  surname: Jocken
  fullname: Jocken, J W E
  organization: Department of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center+
– sequence: 4
  givenname: E E
  surname: Blaak
  fullname: Blaak, E E
  organization: Department of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center+
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28416332$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/24317366$$D View this record in MEDLINE/PubMed
BookMark eNqFkstu1DAUhiNURKeFHWtkCYFYkMGXOJdlVXGTKrEA1pbjnEw8cuxgOy3zOLwpjmYqplUBeWHJ_v5z_c-yE-ssZNlzgtcEs_qd3ro1xYStKSOPshUpqjLnRVOdZCvMcJVjXvLT7CyELcaYc0yfZKe0YKRiZbnKfn0dnI95BD-iME-TgRFslFE7i250HJBEYQKle62QcmOr7f7P9ajTEKXfocmZ3TSAdSYgbZUHGSAgsOA3OwQ_J7CdjrMHJG2HpEmpQkrVhuhlBDSmIK0zOoxJjNw1-BvQmyEuyBZUDE-zx700AZ4d7vPs-4f33y4_5VdfPn6-vLjKFS_KmDNVA-lJI0nBe4wJNLLFhEvCOigxKNpyJhlQytNAsJRFT2mvWEEJUU3btOw8e7OPO3n3Y4YQxaiDAmOkBTcHQWpWMcpqXP8f5ZQ0hBFcJfTlPXTrZm9TI4KWrCGUM07_RaVYuCkrjI-ojTQgtO1dGqFaUosLVtZ1UfOmSNT6ASqdDkatknd6nd7vCF4fCQZIKxqCM_Oy53AXfHGocm5H6MTk9ZgMIG7dlIBXB0AGJU3vpVU6_OHqgpSMLY3QPae8C8FDL5Teey6Vqo0gWCzWFsnaYrG2SNZOorf3RLdx_4LnezwkzG7AH430If43brIIvA
CODEN IJOBDP
CitedBy_id crossref_primary_10_1080_10408398_2018_1536646
crossref_primary_10_1021_acs_jafc_8b04198
crossref_primary_10_3945_ajcn_115_122937
crossref_primary_10_1111_1541_4337_12359
crossref_primary_10_2337_db15_1661
crossref_primary_10_1080_10408398_2014_980499
crossref_primary_10_1016_j_aquaculture_2024_740967
crossref_primary_10_1080_07357907_2022_2115057
crossref_primary_10_3390_molecules23071814
crossref_primary_10_3390_nu9050452
crossref_primary_10_1038_srep17896
crossref_primary_10_1111_obr_12298
crossref_primary_10_1080_10408398_2022_2104805
crossref_primary_10_3945_jn_114_207829
crossref_primary_10_1016_j_clnu_2016_11_002
crossref_primary_10_1007_s00204_022_03391_2
crossref_primary_10_1016_j_biopha_2017_08_070
crossref_primary_10_1080_10408398_2021_1965536
crossref_primary_10_1021_acs_jafc_3c08492
crossref_primary_10_1080_09637486_2018_1452900
crossref_primary_10_1111_jhn_13350
crossref_primary_10_3390_molecules22081329
crossref_primary_10_1007_s00394_019_01946_1
crossref_primary_10_1038_ejcn_2017_89
crossref_primary_10_3390_molecules24091655
crossref_primary_10_1038_nrendo_2016_142
crossref_primary_10_1016_j_arr_2015_01_002
crossref_primary_10_1039_C7FO01236E
crossref_primary_10_1016_j_clnu_2024_09_027
crossref_primary_10_1007_s11010_021_04106_4
crossref_primary_10_1371_journal_pone_0137809
crossref_primary_10_1007_s00394_016_1209_x
crossref_primary_10_1371_journal_pone_0153134
crossref_primary_10_1080_15592294_2016_1278097
crossref_primary_10_2174_1871530323666221107092553
crossref_primary_10_3109_09637486_2015_1035231
crossref_primary_10_1002_oby_23689
crossref_primary_10_1016_j_nut_2020_111045
crossref_primary_10_1021_acs_jafc_7b04647
crossref_primary_10_1155_2018_7406946
crossref_primary_10_1186_s12986_016_0143_5
crossref_primary_10_1002_ptr_6547
crossref_primary_10_15384_kjhp_2014_14_2_59
crossref_primary_10_1113_JP278920
crossref_primary_10_1210_jendso_bvad095
crossref_primary_10_1080_10408398_2014_989958
crossref_primary_10_1080_10408398_2022_2159921
crossref_primary_10_1111_jfbc_12954
crossref_primary_10_3390_nu11040776
crossref_primary_10_1111_obr_12409
crossref_primary_10_2174_0929866528666210127152359
crossref_primary_10_1016_j_jare_2025_01_014
crossref_primary_10_1080_21623945_2018_1469942
crossref_primary_10_1155_2021_6331630
crossref_primary_10_1016_j_cofs_2014_11_008
crossref_primary_10_1186_s12906_024_04487_1
crossref_primary_10_1016_j_foodres_2018_02_027
crossref_primary_10_1096_fj_15_271833
Cites_doi 10.1016/j.nutres.2012.06.002
10.1016/j.metabol.2011.08.003
10.1210/jc.2005-1598
10.3109/13697137.2011.631062
10.1089/jmf.2012.0062
10.1016/j.cmet.2012.09.015
10.1079/BJN20051502
10.1111/nyas.12141
10.1093/jn/137.12.2668
10.1016/S0960-0760(00)00172-2
10.4196/kjpp.2008.12.4.155
10.1152/jappl.1983.55.2.628
10.18632/aging.100445
10.1093/ajcn/87.3.778
10.1210/jc.2010-0822
10.1016/j.bcp.2011.03.012
10.1007/s12263-011-0260-8
10.1371/journal.pone.0051648
10.1016/j.cell.2006.11.013
10.1111/j.1753-0407.2009.00045.x
10.1080/07315724.2007.10719627
10.1017/S0007114509371779
10.1016/j.cmet.2011.10.002
10.1038/sj.ijo.0802926
10.1016/j.phymed.2004.07.001
10.1007/s13105-011-0086-2
10.1111/j.1467-789X.2008.00544.x
10.1038/oby.2010.181
10.1289/ehp.10413
10.1210/jc.2010-0702
10.1111/nyas.12185
10.1016/j.ecl.2008.09.002
10.1093/ajcn/70.6.1040
10.1152/jappl.1997.83.6.2064
10.1038/ajh.2009.228
10.1159/000084175
10.2337/dc06-0560
10.1038/ejcn.2010.47
10.1079/BJN20051580
10.1016/j.physbeh.2007.10.010
10.2337/diabetes.50.11.2548
10.1016/j.diabres.2012.02.029
10.2337/db10-0519
10.1113/jphysiol.1949.sp004363
10.1152/ajpregu.00693.2004
10.1210/jcem.87.5.8628
10.1038/nature05354
10.1111/j.1464-5491.2008.02417.x
10.1016/j.jsbmb.2005.04.033
10.2337/db12-0975
10.1271/bbb.80563
10.1056/NEJM200105033441801
ContentType Journal Article
Copyright Macmillan Publishers Limited 2014
2015 INIST-CNRS
COPYRIGHT 2014 Nature Publishing Group
Copyright Nature Publishing Group May 2014
Macmillan Publishers Limited 2014.
Copyright_xml – notice: Macmillan Publishers Limited 2014
– notice: 2015 INIST-CNRS
– notice: COPYRIGHT 2014 Nature Publishing Group
– notice: Copyright Nature Publishing Group May 2014
– notice: Macmillan Publishers Limited 2014.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T2
7TK
7TS
7X2
7X7
7XB
88E
88G
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ATCPS
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0K
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
DOI 10.1038/ijo.2013.231
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health and Safety Science Abstracts (Full archive)
Neurosciences Abstracts
Physical Education Index
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Agriculture Science Database
ProQuest Health & Medical Collection
Medical Database
Psychology Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
Physical Education Index
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Agricultural & Environmental Science Collection
Biological Science Collection
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Physical Education Index


MEDLINE
Agricultural Science Database

Agricultural Science Database
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
Diet & Clinical Nutrition
Recreation & Sports
EISSN 1476-5497
EndPage 706
ExternalDocumentID 3294506381
A368848594
24317366
28416332
10_1038_ijo_2013_231
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Netherlands
GeographicLocations_xml – name: Netherlands
GroupedDBID .55
.GJ
29J
36B
39C
5RE
7X2
7X7
8R4
8R5
A8Z
ABDBF
ABOCM
ABUWG
ACUHS
ADBBV
AFFNX
AI.
ALMA_UNASSIGNED_HOLDINGS
ATCPS
AZQEC
B0M
BAWUL
BENPR
BHPHI
BPHCQ
DIK
DWQXO
EAD
EAP
EBC
EBD
EBS
EMB
EMK
EMOBN
EPL
ESX
F5P
FYUFA
GNUQQ
HCIFZ
IAO
IHR
ITC
J5H
M0K
M1P
M2M
MVM
NAO
OK1
Q2X
RNT
RNTTT
SV3
TUS
VH1
WH7
X7M
ZGI
ZXP
~8M
AAYXX
CITATION
IQODW
---
-Q-
..I
.L3
.XZ
0R~
1CY
2FS
2WC
4.4
406
53G
5GY
70F
88E
8AO
8C1
8FE
8FH
8FI
8FJ
AACDK
AAHBH
AANZL
AASML
AATNV
AAWTL
AAYZH
ABAKF
ABAWZ
ABCQX
ABDBE
ABIVO
ABJNI
ABLJU
ABZZP
ACAOD
ACGFS
ACKTT
ACPRK
ACRQY
ACZOJ
ADHUB
AEFQL
AEJRE
AEMSY
AENEX
AEUYN
AEVLU
AEXYK
AFBBN
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJRNO
ALFFA
ALIPV
AMYLF
APEBS
AXYYD
AYFIA
BBNVY
BKKNO
BVXVI
CCPQU
CGR
CS3
CUY
CVF
DNIVK
DPUIP
DU5
E3Z
EBLON
ECM
EE.
EIF
EIOEI
EJD
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
HMCUK
HZ~
IHW
INH
INR
IPY
IWAJR
JSO
JZLTJ
KQ8
L7B
M7P
NPM
NQJWS
O9-
OVD
P2P
P6G
PHGZT
PQQKQ
PROAC
PSQYO
PSYQQ
RNS
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
UKHRP
YCJ
~KM
3V.
7T2
7TK
7TS
7XB
8FK
C1K
K9.
LK8
PHGZM
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
ABBRH
ABFSG
ABRTQ
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
ID FETCH-LOGICAL-c546t-3c8e1f19a145f001e9ab015a13de60ec2b53a3e2250560aa4f22fc34211c9b9b3
IEDL.DBID 7X7
ISSN 0307-0565
1476-5497
IngestDate Fri Jul 11 09:38:55 EDT 2025
Mon Jul 21 10:31:24 EDT 2025
Thu Jul 17 01:56:40 EDT 2025
Thu Jul 17 02:00:24 EDT 2025
Tue Jun 17 21:15:17 EDT 2025
Tue Jun 10 20:45:46 EDT 2025
Thu May 22 21:20:27 EDT 2025
Thu Apr 03 07:02:07 EDT 2025
Wed Apr 02 07:17:44 EDT 2025
Thu Apr 24 22:53:55 EDT 2025
Tue Jul 01 03:01:52 EDT 2025
Fri Feb 21 02:39:37 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords epigallocatechin-gallate
polyphenols
human substrate metabolism
resveratrol
Short term
Energy metabolism
Body weight
Overweight
Polyphenol
Energetic cost
Resveratrol
Supplementation
Nutritional status
Food
Human
Obesity
Nutrition
Nutrition disorder
Metabolic diseases
Corporal biometry
Increase
Antioxidant
Stilbene derivatives
Feeding
Substrate
Diet
Phenols
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c546t-3c8e1f19a145f001e9ab015a13de60ec2b53a3e2250560aa4f22fc34211c9b9b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
PMID 24317366
PQID 1520967002
PQPubID 38864
PageCount 9
ParticipantIDs proquest_miscellaneous_1837323808
proquest_miscellaneous_1521913107
proquest_journals_2639125352
proquest_journals_1520967002
gale_infotracmisc_A368848594
gale_infotracacademiconefile_A368848594
gale_healthsolutions_A368848594
pubmed_primary_24317366
pascalfrancis_primary_28416332
crossref_citationtrail_10_1038_ijo_2013_231
crossref_primary_10_1038_ijo_2013_231
springer_journals_10_1038_ijo_2013_231
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-05-01
PublicationDateYYYYMMDD 2014-05-01
PublicationDate_xml – month: 05
  year: 2014
  text: 2014-05-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: Basingstoke
– name: England
PublicationTitle International Journal of Obesity
PublicationTitleAbbrev Int J Obes
PublicationTitleAlternate Int J Obes (Lond)
PublicationYear 2014
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Lonac, Richards, Schweder, Johnson, Bell (CR18) 2010; 19
Hamman, Wing, Edelstein, Lachin, Bray, Delahanty (CR53) 2006; 29
Murase, Haramizu, Shimotoyodome, Nagasawa, Tokimitsu (CR38) 2005; 288
Thielecke, Rahn, Bohnke, Adams, Birkenfeld, Jordan (CR15) 2010; 64
Ullmann, Haller, Bakker, Brink, Weber (CR29) 2005; 12
Lara-Castro, Garvey (CR3) 2008; 37
Rayalam, Della-Fera, Yang, Park, Ambati, Baile (CR26) 2007; 137
Tuomilehto, Lindstrom, Eriksson, Valle, Hamalainen, Ilanne-Parikka (CR8) 2001; 344
Mohamed Salih, Nallasamy, Muniyandi, Periyasami, Carani Venkatraman (CR21) 2009; 1
Diepvens, Kovacs, Nijs, Vogels, Westerterp-Plantenga (CR33) 2005; 94
Goossens (CR2) 2008; 94
Thandapilly, Wojciechowski, Behbahani, Louis, Yu, Juric (CR39) 2011; 23
Lee, Kim (CR44) 2009; 73
Zhang, Chen, Zheng, Zeng, Li, Xiao (CR48) 2012; 97
Poulsen, Vestergaard, Clasen, Radko, Christensen, Stodkilde-Jorgensen (CR25) 2012; 62
Timmers, Hesselink, Schrauwen (CR51) 2013; 1290
Yeung, Zhang, Mumford, Ye, Trevisan, Chen (CR46) 2010; 95
Venables, Hulston, Cox, Jeukendrup (CR19) 2008; 87
Hoeks, van Herpen, Mensink, Moonen-Kornips, van Beurden, Hesselink (CR50) 2010; 59
Arunkumar, Anuradha (CR24) 2012; 32
Rosenbaum, Murphy, Heymsfield, Matthews, Leibel (CR41) 2002; 87
Timmers, Konings, Bilet, Houtkooper, van de Weijer, Goossens (CR12) 2011; 14
Cederroth, Vinciguerra, Kuhne, Madani, Doerge, Visser (CR22) 2007; 115
Mensink, Blaak, van Baak, Wagenmakers, Saris (CR4) 2001; 50
Lagouge, Argmann, Gerhart-Hines, Meziane, Lerin, Daussin (CR11) 2006; 127
Poulsen, Jorgensen, Jessen, Richelsen, Pedersen (CR52) 2013; 1290
Llaneza, Gonzalez, Fernandez-Inarrea, Alonso, Diaz, Perez-Lopez (CR23) 2012; 15
Yoshino, Conte, Fontana, Mittendorfer, Imai, Schechtman (CR34) 2012; 16
Chomentowski, Coen, Radikova, Goodpaster, Toledo (CR6) 2011; 96
Frayn (CR31) 1983; 55
Arias, Macarulla, Aguirre, Martinez-Castano, Gomez-Zorita, Miranda (CR35) 2012; 67
Klaus, Pultz, Thone-Reineke, Wolfram (CR37) 2005; 29
Klaus, Keipert, Rossmeisl, Kopecky (CR43) 2012; 7
Szkudelska, Nogowski, Szkudelski (CR49) 2000; 75
Cardoso, Salgado, Cesar Mde, Donado-Pestana (CR32) 2012; 16
Szkudelski, Nogowski, Pruszynska-Oszmalek, Kaczmarek, Szkudelska (CR42) 2005; 96
Blaak, Hul, Verdich, Stich, Martinez, Petersen (CR5) 2006; 91
Baur, Pearson, Price, Jamieson, Lerin, Kalra (CR10) 2006; 444
Timmers, Auwerx, Schrauwen (CR45) 2012; 4
Corpeleijn, Saris, Blaak (CR1) 2009; 10
Roumen, Corpeleijn, Feskens, Mensink, Saris, Blaak (CR9) 2008; 25
Kim, Jin, Choi, Park (CR36) 2011; 81
Berube-Parent, Pelletier, Dore, Tremblay (CR16) 2005; 94
Kang, Hong, Guan, Kim, Yang, Koh (CR47) 2011; 61
Chen, Bakhiet, Hart, Holtzman (CR28) 2005; 49
Gregersen, Bitz, Krog-Mikkelsen, Hels, Kovacs, Rycroft (CR17) 2009; 102
Schoffelen, Westerterp, Saris, Ten Hoor (CR27) 1997; 83
Van Can, Van Dijk, Goossens, Jocken, Hospers, Blaak (CR20) 2010; 11
Boschmann, Thielecke (CR13) 2007; 26
Weir (CR30) 1949; 109
Woo, Na, Lim (CR40) 2008; 12
van de Weijer, Sparks, Phielix, Meex, van Herpen, Hesselink (CR7) 2013; 8
Dulloo, Duret, Rohrer, Girardier, Mensi, Fathi (CR14) 1999; 70
K Szkudelska (BFijo2013231_CR49) 2000; 75
EE Blaak (BFijo2013231_CR5) 2006; 91
S Timmers (BFijo2013231_CR12) 2011; 14
S Mohamed Salih (BFijo2013231_CR21) 2009; 1
S Timmers (BFijo2013231_CR51) 2013; 1290
CR Cederroth (BFijo2013231_CR22) 2007; 115
N Arias (BFijo2013231_CR35) 2012; 67
S Rayalam (BFijo2013231_CR26) 2007; 137
C Lara-Castro (BFijo2013231_CR3) 2008; 37
AG Dulloo (BFijo2013231_CR14) 1999; 70
SC Woo (BFijo2013231_CR40) 2008; 12
RF Hamman (BFijo2013231_CR53) 2006; 29
MM Poulsen (BFijo2013231_CR52) 2013; 1290
E Corpeleijn (BFijo2013231_CR1) 2009; 10
M Lagouge (BFijo2013231_CR11) 2006; 127
J Van Can (BFijo2013231_CR20) 2010; 11
JB Weir (BFijo2013231_CR30) 1949; 109
E Arunkumar (BFijo2013231_CR24) 2012; 32
W Kang (BFijo2013231_CR47) 2011; 61
J Tuomilehto (BFijo2013231_CR8) 2001; 344
J Yoshino (BFijo2013231_CR34) 2012; 16
S Klaus (BFijo2013231_CR43) 2012; 7
MS Lee (BFijo2013231_CR44) 2009; 73
M Rosenbaum (BFijo2013231_CR41) 2002; 87
S Kim (BFijo2013231_CR36) 2011; 81
CY Chen (BFijo2013231_CR28) 2005; 49
J Zhang (BFijo2013231_CR48) 2012; 97
MM Poulsen (BFijo2013231_CR25) 2012; 62
S Timmers (BFijo2013231_CR45) 2012; 4
GH Goossens (BFijo2013231_CR2) 2008; 94
T Murase (BFijo2013231_CR38) 2005; 288
MC Venables (BFijo2013231_CR19) 2008; 87
JA Baur (BFijo2013231_CR10) 2006; 444
GA Cardoso (BFijo2013231_CR32) 2012; 16
K Diepvens (BFijo2013231_CR33) 2005; 94
T van de Weijer (BFijo2013231_CR7) 2013; 8
P Chomentowski (BFijo2013231_CR6) 2011; 96
PF Schoffelen (BFijo2013231_CR27) 1997; 83
J Hoeks (BFijo2013231_CR50) 2010; 59
P Llaneza (BFijo2013231_CR23) 2012; 15
U Ullmann (BFijo2013231_CR29) 2005; 12
M Mensink (BFijo2013231_CR4) 2001; 50
KN Frayn (BFijo2013231_CR31) 1983; 55
SJ Thandapilly (BFijo2013231_CR39) 2011; 23
MC Lonac (BFijo2013231_CR18) 2010; 19
F Thielecke (BFijo2013231_CR15) 2010; 64
S Berube-Parent (BFijo2013231_CR16) 2005; 94
M Boschmann (BFijo2013231_CR13) 2007; 26
S Klaus (BFijo2013231_CR37) 2005; 29
T Szkudelski (BFijo2013231_CR42) 2005; 96
NT Gregersen (BFijo2013231_CR17) 2009; 102
EH Yeung (BFijo2013231_CR46) 2010; 95
C Roumen (BFijo2013231_CR9) 2008; 25
21455758 - J Physiol Biochem. 2011 Sep;67(3):471-7
22497970 - Diabetes Res Clin Pract. 2012 Sep;97(3):474-82
11679433 - Diabetes. 2001 Nov;50(11):2548-54
21106709 - J Clin Endocrinol Metab. 2011 Feb;96(2):494-503
22139637 - Genes Nutr. 2012 Jul;7(3):369-86
18029481 - J Nutr. 2007 Dec;137(12):2668-73
23418416 - PLoS One. 2013;8(2):e51648
Int J Obes (Lond). 2014 May;38(5):752
19026935 - Endocrinol Metab Clin North Am. 2008 Dec;37(4):841-56
23855469 - Ann N Y Acad Sci. 2013 Jul;1290:83-9
9390982 - J Appl Physiol (1985). 1997 Dec;83(6):2064-72
16936160 - Diabetes Care. 2006 Sep;29(9):2102-7
17112576 - Cell. 2006 Dec 15;127(6):1109-22
19445822 - Br J Nutr. 2009 Oct;102(8):1187-94
16008116 - Phytomedicine. 2005 Jun;12(6-7):410-5
22055504 - Cell Metab. 2011 Nov 2;14 (5):612-22
15738931 - Int J Obes (Lond). 2005 Jun;29(6):615-23
20843950 - J Clin Endocrinol Metab. 2010 Dec;95(12):5435-42
20372175 - Eur J Clin Nutr. 2010 Jul;64(7):704-13
18445174 - Diabet Med. 2008 May;25(5):597-605
11333990 - N Engl J Med. 2001 May 3;344(18):1343-50
6618956 - J Appl Physiol Respir Environ Exerc Physiol. 1983 Aug;55(2):628-34
18326618 - Am J Clin Nutr. 2008 Mar;87(3):778-84
15394301 - J Physiol. 1949 Aug;109(1-2):1-9
20725062 - Obesity (Silver Spring). 2011 Feb;19(2):298-304
20923528 - J Diabetes. 2009 Dec;1(4):278-87
22436213 - Aging (Albany NY). 2012 Mar;4(3):146-58
10584049 - Am J Clin Nutr. 1999 Dec;70(6):1040-5
23140132 - J Med Food. 2013 Feb;16(2):120-7
16351782 - Br J Nutr. 2005 Dec;94(6):1026-34
11994393 - J Clin Endocrinol Metab. 2002 May;87(5):2391-4
19967050 - Korean J Physiol Pharmacol. 2008 Aug;12(4):155-64
21439945 - Biochem Pharmacol. 2011 Jun 1;81(11):1343-51
18037457 - Physiol Behav. 2008 May 23;94(2):206-18
20573749 - Diabetes. 2010 Sep;59(9):2117-25
11282281 - J Steroid Biochem Mol Biol. 2000 Dec 31;75(4-5):265-71
17906192 - J Am Coll Nutr. 2007 Aug;26(4):389S-395S
15970440 - J Steroid Biochem Mol Biol. 2005 Aug;96(3-4):301-7
19202275 - Biosci Biotechnol Biochem. 2009 Feb;73(2):434-6
15735366 - Ann Nutr Metab. 2005 Jan-Feb;49(1):33-41
22191384 - Climacteric. 2012 Dec;15(6):611-20
15563575 - Am J Physiol Regul Integr Comp Physiol. 2005 Mar;288(3):R708-15
17938737 - Environ Health Perspect. 2007 Oct;115(10):1467-73
23102619 - Cell Metab. 2012 Nov 7;16(5):658-64
16176615 - Br J Nutr. 2005 Sep;94(3):432-6
21945106 - Metabolism. 2012 Mar;61(3):424-33
23193181 - Diabetes. 2013 Apr;62(4):1186-95
19207879 - Obes Rev. 2009 Mar;10(2):178-93
19942861 - Am J Hypertens. 2010 Feb;23 (2):192-6
23855468 - Ann N Y Acad Sci. 2013 Jul;1290:74-82
17086191 - Nature. 2006 Nov 16;444(7117):337-42
22935345 - Nutr Res. 2012 Aug;32(8):617-25
16449343 - J Clin Endocrinol Metab. 2006 Apr;91(4):1462-9
References_xml – volume: 32
  start-page: 617
  year: 2012
  end-page: 625
  ident: CR24
  article-title: Genistein promotes insulin action through adenosine monophosphate-activated protein kinase activation and p70 ribosomal protein S6 kinase 1 inhibition in the skeletal muscle of mice fed a high energy diet
  publication-title: Nutr Res
  doi: 10.1016/j.nutres.2012.06.002
– volume: 61
  start-page: 424
  year: 2011
  end-page: 433
  ident: CR47
  article-title: Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: and experiments in rodents
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2011.08.003
– volume: 91
  start-page: 1462
  year: 2006
  end-page: 1469
  ident: CR5
  article-title: Fat oxidation before and after a high fat load in the obese insulin-resistant state
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-1598
– volume: 15
  start-page: 611
  year: 2012
  end-page: 620
  ident: CR23
  article-title: Soy isoflavones improve insulin sensitivity without changing serum leptin among postmenopausal women
  publication-title: Climacteric
  doi: 10.3109/13697137.2011.631062
– volume: 16
  start-page: 120
  year: 2012
  end-page: 127
  ident: CR32
  article-title: The effects of green tea consumption and resistance training on body composition and resting metabolic rate in overweight or obese women
  publication-title: J Med Food
  doi: 10.1089/jmf.2012.0062
– volume: 16
  start-page: 658
  year: 2012
  end-page: 664
  ident: CR34
  article-title: Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2012.09.015
– volume: 94
  start-page: 432
  year: 2005
  end-page: 436
  ident: CR16
  article-title: Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men
  publication-title: Br J Nutr
  doi: 10.1079/BJN20051502
– volume: 1290
  start-page: 74
  year: 2013
  end-page: 82
  ident: CR52
  article-title: Resveratrol in metabolic health: an overview of the current evidence and perspectives
  publication-title: Ann NY Acad Sci
  doi: 10.1111/nyas.12141
– volume: 137
  start-page: 2668
  year: 2007
  end-page: 2673
  ident: CR26
  article-title: Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes
  publication-title: J Nutr
  doi: 10.1093/jn/137.12.2668
– volume: 75
  start-page: 265
  year: 2000
  end-page: 271
  ident: CR49
  article-title: Genistein affects lipogenesis and lipolysis in isolated rat adipocytes
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/S0960-0760(00)00172-2
– volume: 12
  start-page: 155
  year: 2008
  end-page: 164
  ident: CR40
  article-title: Resveratrol inhibits nicotinic stimulation-evoked catecholamine release from the adrenal medulla
  publication-title: Korean J Physiol Pharmacol
  doi: 10.4196/kjpp.2008.12.4.155
– volume: 55
  start-page: 628
  year: 1983
  end-page: 634
  ident: CR31
  article-title: Calculation of substrate oxidation rates from gaseous exchange
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.1983.55.2.628
– volume: 4
  start-page: 146
  year: 2012
  end-page: 158
  ident: CR45
  article-title: The journey of resveratrol from yeast to human
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.100445
– volume: 87
  start-page: 778
  year: 2008
  end-page: 784
  ident: CR19
  article-title: Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/87.3.778
– volume: 344
  start-page: 1343
  year: 2001
  end-page: 1350
  ident: CR8
  article-title: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
  publication-title: N Engl J Med
– volume: 96
  start-page: 494
  year: 2011
  end-page: 503
  ident: CR6
  article-title: Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2010-0822
– volume: 81
  start-page: 1343
  year: 2011
  end-page: 1351
  ident: CR36
  article-title: Resveratrol exerts anti-obesity effects mechanisms involving down-regulation of adipogenic and inflammatory processes in mice
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2011.03.012
– volume: 7
  start-page: 369
  year: 2012
  end-page: 386
  ident: CR43
  article-title: Augmenting energy expenditure by mitochondrial uncoupling: a role of AMP-activated protein kinase
  publication-title: Genes Nutr
  doi: 10.1007/s12263-011-0260-8
– volume: 8
  start-page: e51648
  year: 2013
  ident: CR7
  article-title: Relationships between mitochondrial function and metabolic flexibility in type 2 diabetes mellitus
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0051648
– volume: 127
  start-page: 1109
  year: 2006
  end-page: 1122
  ident: CR11
  article-title: Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha
  publication-title: Cell
  doi: 10.1016/j.cell.2006.11.013
– volume: 1
  start-page: 278
  year: 2009
  end-page: 287
  ident: CR21
  article-title: Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance
  publication-title: J Diabetes
  doi: 10.1111/j.1753-0407.2009.00045.x
– volume: 26
  start-page: 389S
  year: 2007
  end-page: 395SS
  ident: CR13
  article-title: The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study
  publication-title: J Am Coll Nutr
  doi: 10.1080/07315724.2007.10719627
– volume: 102
  start-page: 1187
  year: 2009
  end-page: 1194
  ident: CR17
  article-title: Effect of moderate intakes of different tea catechins and caffeine on acute measures of energy metabolism under sedentary conditions
  publication-title: Br J Nutr
  doi: 10.1017/S0007114509371779
– volume: 14
  start-page: 612
  year: 2011
  end-page: 622
  ident: CR12
  article-title: Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2011.10.002
– volume: 29
  start-page: 615
  year: 2005
  end-page: 623
  ident: CR37
  article-title: Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation
  publication-title: Int J Obes (Lond)
  doi: 10.1038/sj.ijo.0802926
– volume: 12
  start-page: 410
  year: 2005
  end-page: 415
  ident: CR29
  article-title: Epigallocatechin gallate (EGCG) (TEAVIGO) does not impair nonhaem-iron absorption in man
  publication-title: Phytomedicine
  doi: 10.1016/j.phymed.2004.07.001
– volume: 67
  start-page: 471
  year: 2012
  end-page: 477
  ident: CR35
  article-title: The combination of resveratrol and conjugated linoleic acid is not useful in preventing obesity
  publication-title: J Physiol Biochem
  doi: 10.1007/s13105-011-0086-2
– volume: 10
  start-page: 178
  year: 2009
  end-page: 193
  ident: CR1
  article-title: Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle
  publication-title: Obes Rev
  doi: 10.1111/j.1467-789X.2008.00544.x
– volume: 19
  start-page: 298
  year: 2010
  end-page: 304
  ident: CR18
  article-title: Influence of short-term consumption of the caffeine-free, epigallocatechin-3-gallate supplement, Teavigo, on resting metabolism and the thermic effect of feeding
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2010.181
– volume: 115
  start-page: 1467
  year: 2007
  end-page: 1473
  ident: CR22
  article-title: A phytoestrogen-rich diet increases energy expenditure and decreases adiposity in mice
  publication-title: Environ Health Perspect
  doi: 10.1289/ehp.10413
– volume: 95
  start-page: 5435
  year: 2010
  end-page: 5442
  ident: CR46
  article-title: Longitudinal study of insulin resistance and sex hormones over the menstrual cycle: the BioCycle Study
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2010-0702
– volume: 1290
  start-page: 83
  year: 2013
  end-page: 89
  ident: CR51
  article-title: Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?
  publication-title: Ann NY Acad Sci
  doi: 10.1111/nyas.12185
– volume: 37
  start-page: 841
  year: 2008
  end-page: 856
  ident: CR3
  article-title: Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome
  publication-title: Endocrinol Metab Clin North Am
  doi: 10.1016/j.ecl.2008.09.002
– volume: 70
  start-page: 1040
  year: 1999
  end-page: 1045
  ident: CR14
  article-title: Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/70.6.1040
– volume: 83
  start-page: 2064
  year: 1997
  end-page: 2072
  ident: CR27
  article-title: A dual-respiration chamber system with automated calibration
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.1997.83.6.2064
– volume: 23
  start-page: 192
  year: 2011
  end-page: 196
  ident: CR39
  article-title: Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure
  publication-title: Am J Hypertens
  doi: 10.1038/ajh.2009.228
– volume: 49
  start-page: 33
  year: 2005
  end-page: 41
  ident: CR28
  article-title: Isoflavones improve plasma homocysteine status and antioxidant defense system in healthy young men at rest but do not ameliorate oxidative stress induced by 80% VO2pk exercise
  publication-title: Ann Nutr Metab
  doi: 10.1159/000084175
– volume: 29
  start-page: 2102
  year: 2006
  end-page: 2107
  ident: CR53
  article-title: Effect of weight loss with lifestyle intervention on risk of diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc06-0560
– volume: 64
  start-page: 704
  year: 2010
  end-page: 713
  ident: CR15
  article-title: Epigallocatechin-3-gallate and postprandial fat oxidation in overweight/obese male volunteers: a pilot study
  publication-title: Eur J Clin Nutr
  doi: 10.1038/ejcn.2010.47
– volume: 94
  start-page: 1026
  year: 2005
  end-page: 1034
  ident: CR33
  article-title: Effect of green tea on resting energy expenditure and substrate oxidation during weight loss in overweight females
  publication-title: Br J Nutr
  doi: 10.1079/BJN20051580
– volume: 94
  start-page: 206
  year: 2008
  end-page: 218
  ident: CR2
  article-title: The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance
  publication-title: Physiol Behav
  doi: 10.1016/j.physbeh.2007.10.010
– volume: 50
  start-page: 2548
  year: 2001
  end-page: 2554
  ident: CR4
  article-title: Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes
  publication-title: Diabetes
  doi: 10.2337/diabetes.50.11.2548
– volume: 97
  start-page: 474
  year: 2012
  end-page: 482
  ident: CR48
  article-title: The protective effect of resveratrol on islet insulin secretion and morphology in mice on a high-fat diet
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2012.02.029
– volume: 59
  start-page: 2117
  year: 2010
  end-page: 2125
  ident: CR50
  article-title: Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance
  publication-title: Diabetes
  doi: 10.2337/db10-0519
– volume: 109
  start-page: 1
  year: 1949
  end-page: 9
  ident: CR30
  article-title: New methods for calculating metabolic rate with special reference to protein metabolism
  publication-title: J Physiol
  doi: 10.1113/jphysiol.1949.sp004363
– volume: 288
  start-page: R708
  year: 2005
  end-page: R715
  ident: CR38
  article-title: Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00693.2004
– volume: 87
  start-page: 2391
  year: 2002
  end-page: 2394
  ident: CR41
  article-title: Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.87.5.8628
– volume: 444
  start-page: 337
  year: 2006
  end-page: 342
  ident: CR10
  article-title: Resveratrol improves health and survival of mice on a high-calorie diet
  publication-title: Nature
  doi: 10.1038/nature05354
– volume: 11
  start-page: 206
  year: 2010
  ident: CR20
  article-title: A 3 day EGCG supplementation reduced lactate in skeletal muscle in overweight subjects
  publication-title: Obes Rev
– volume: 25
  start-page: 597
  year: 2008
  end-page: 605
  ident: CR9
  article-title: Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2008.02417.x
– volume: 96
  start-page: 301
  year: 2005
  end-page: 307
  ident: CR42
  article-title: Genistein restricts leptin secretion from rat adipocytes
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2005.04.033
– volume: 62
  start-page: 1186
  year: 2012
  end-page: 1195
  ident: CR25
  article-title: High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition
  publication-title: Diabetes
  doi: 10.2337/db12-0975
– volume: 73
  start-page: 434
  year: 2009
  end-page: 436
  ident: CR44
  article-title: (-)-Epigallocatechin-3-gallate enhances uncoupling protein 2 gene expression in 3T3-L1 adipocytes
  publication-title: Biosci Biotechnol Biochem
  doi: 10.1271/bbb.80563
– volume: 14
  start-page: 612
  year: 2011
  ident: BFijo2013231_CR12
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2011.10.002
– volume: 29
  start-page: 2102
  year: 2006
  ident: BFijo2013231_CR53
  publication-title: Diabetes Care
  doi: 10.2337/dc06-0560
– volume: 29
  start-page: 615
  year: 2005
  ident: BFijo2013231_CR37
  publication-title: Int J Obes (Lond)
  doi: 10.1038/sj.ijo.0802926
– volume: 102
  start-page: 1187
  year: 2009
  ident: BFijo2013231_CR17
  publication-title: Br J Nutr
  doi: 10.1017/S0007114509371779
– volume: 7
  start-page: 369
  year: 2012
  ident: BFijo2013231_CR43
  publication-title: Genes Nutr
  doi: 10.1007/s12263-011-0260-8
– volume: 83
  start-page: 2064
  year: 1997
  ident: BFijo2013231_CR27
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.1997.83.6.2064
– volume: 49
  start-page: 33
  year: 2005
  ident: BFijo2013231_CR28
  publication-title: Ann Nutr Metab
  doi: 10.1159/000084175
– volume: 1290
  start-page: 83
  year: 2013
  ident: BFijo2013231_CR51
  publication-title: Ann NY Acad Sci
  doi: 10.1111/nyas.12185
– volume: 10
  start-page: 178
  year: 2009
  ident: BFijo2013231_CR1
  publication-title: Obes Rev
  doi: 10.1111/j.1467-789X.2008.00544.x
– volume: 37
  start-page: 841
  year: 2008
  ident: BFijo2013231_CR3
  publication-title: Endocrinol Metab Clin North Am
  doi: 10.1016/j.ecl.2008.09.002
– volume: 4
  start-page: 146
  year: 2012
  ident: BFijo2013231_CR45
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.100445
– volume: 288
  start-page: R708
  year: 2005
  ident: BFijo2013231_CR38
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00693.2004
– volume: 127
  start-page: 1109
  year: 2006
  ident: BFijo2013231_CR11
  publication-title: Cell
  doi: 10.1016/j.cell.2006.11.013
– volume: 8
  start-page: e51648
  year: 2013
  ident: BFijo2013231_CR7
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0051648
– volume: 87
  start-page: 778
  year: 2008
  ident: BFijo2013231_CR19
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/87.3.778
– volume: 67
  start-page: 471
  year: 2012
  ident: BFijo2013231_CR35
  publication-title: J Physiol Biochem
  doi: 10.1007/s13105-011-0086-2
– volume: 11
  start-page: 206
  year: 2010
  ident: BFijo2013231_CR20
  publication-title: Obes Rev
– volume: 96
  start-page: 301
  year: 2005
  ident: BFijo2013231_CR42
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2005.04.033
– volume: 81
  start-page: 1343
  year: 2011
  ident: BFijo2013231_CR36
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2011.03.012
– volume: 16
  start-page: 120
  year: 2012
  ident: BFijo2013231_CR32
  publication-title: J Med Food
  doi: 10.1089/jmf.2012.0062
– volume: 64
  start-page: 704
  year: 2010
  ident: BFijo2013231_CR15
  publication-title: Eur J Clin Nutr
  doi: 10.1038/ejcn.2010.47
– volume: 32
  start-page: 617
  year: 2012
  ident: BFijo2013231_CR24
  publication-title: Nutr Res
  doi: 10.1016/j.nutres.2012.06.002
– volume: 344
  start-page: 1343
  year: 2001
  ident: BFijo2013231_CR8
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200105033441801
– volume: 96
  start-page: 494
  year: 2011
  ident: BFijo2013231_CR6
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2010-0822
– volume: 94
  start-page: 206
  year: 2008
  ident: BFijo2013231_CR2
  publication-title: Physiol Behav
  doi: 10.1016/j.physbeh.2007.10.010
– volume: 25
  start-page: 597
  year: 2008
  ident: BFijo2013231_CR9
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2008.02417.x
– volume: 26
  start-page: 389S
  year: 2007
  ident: BFijo2013231_CR13
  publication-title: J Am Coll Nutr
  doi: 10.1080/07315724.2007.10719627
– volume: 70
  start-page: 1040
  year: 1999
  ident: BFijo2013231_CR14
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/70.6.1040
– volume: 94
  start-page: 432
  year: 2005
  ident: BFijo2013231_CR16
  publication-title: Br J Nutr
  doi: 10.1079/BJN20051502
– volume: 62
  start-page: 1186
  year: 2012
  ident: BFijo2013231_CR25
  publication-title: Diabetes
  doi: 10.2337/db12-0975
– volume: 95
  start-page: 5435
  year: 2010
  ident: BFijo2013231_CR46
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2010-0702
– volume: 97
  start-page: 474
  year: 2012
  ident: BFijo2013231_CR48
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2012.02.029
– volume: 19
  start-page: 298
  year: 2010
  ident: BFijo2013231_CR18
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2010.181
– volume: 91
  start-page: 1462
  year: 2006
  ident: BFijo2013231_CR5
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-1598
– volume: 1
  start-page: 278
  year: 2009
  ident: BFijo2013231_CR21
  publication-title: J Diabetes
  doi: 10.1111/j.1753-0407.2009.00045.x
– volume: 1290
  start-page: 74
  year: 2013
  ident: BFijo2013231_CR52
  publication-title: Ann NY Acad Sci
  doi: 10.1111/nyas.12141
– volume: 75
  start-page: 265
  year: 2000
  ident: BFijo2013231_CR49
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/S0960-0760(00)00172-2
– volume: 15
  start-page: 611
  year: 2012
  ident: BFijo2013231_CR23
  publication-title: Climacteric
  doi: 10.3109/13697137.2011.631062
– volume: 73
  start-page: 434
  year: 2009
  ident: BFijo2013231_CR44
  publication-title: Biosci Biotechnol Biochem
  doi: 10.1271/bbb.80563
– volume: 444
  start-page: 337
  year: 2006
  ident: BFijo2013231_CR10
  publication-title: Nature
  doi: 10.1038/nature05354
– volume: 137
  start-page: 2668
  year: 2007
  ident: BFijo2013231_CR26
  publication-title: J Nutr
  doi: 10.1093/jn/137.12.2668
– volume: 12
  start-page: 155
  year: 2008
  ident: BFijo2013231_CR40
  publication-title: Korean J Physiol Pharmacol
  doi: 10.4196/kjpp.2008.12.4.155
– volume: 23
  start-page: 192
  year: 2011
  ident: BFijo2013231_CR39
  publication-title: Am J Hypertens
  doi: 10.1038/ajh.2009.228
– volume: 115
  start-page: 1467
  year: 2007
  ident: BFijo2013231_CR22
  publication-title: Environ Health Perspect
  doi: 10.1289/ehp.10413
– volume: 16
  start-page: 658
  year: 2012
  ident: BFijo2013231_CR34
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2012.09.015
– volume: 87
  start-page: 2391
  year: 2002
  ident: BFijo2013231_CR41
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.87.5.8628
– volume: 50
  start-page: 2548
  year: 2001
  ident: BFijo2013231_CR4
  publication-title: Diabetes
  doi: 10.2337/diabetes.50.11.2548
– volume: 59
  start-page: 2117
  year: 2010
  ident: BFijo2013231_CR50
  publication-title: Diabetes
  doi: 10.2337/db10-0519
– volume: 94
  start-page: 1026
  year: 2005
  ident: BFijo2013231_CR33
  publication-title: Br J Nutr
  doi: 10.1079/BJN20051580
– volume: 109
  start-page: 1
  year: 1949
  ident: BFijo2013231_CR30
  publication-title: J Physiol
  doi: 10.1113/jphysiol.1949.sp004363
– volume: 61
  start-page: 424
  year: 2011
  ident: BFijo2013231_CR47
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2011.08.003
– volume: 12
  start-page: 410
  year: 2005
  ident: BFijo2013231_CR29
  publication-title: Phytomedicine
  doi: 10.1016/j.phymed.2004.07.001
– volume: 55
  start-page: 628
  year: 1983
  ident: BFijo2013231_CR31
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.1983.55.2.628
– reference: 16351782 - Br J Nutr. 2005 Dec;94(6):1026-34
– reference: 21106709 - J Clin Endocrinol Metab. 2011 Feb;96(2):494-503
– reference: 21945106 - Metabolism. 2012 Mar;61(3):424-33
– reference: 19445822 - Br J Nutr. 2009 Oct;102(8):1187-94
– reference: 20843950 - J Clin Endocrinol Metab. 2010 Dec;95(12):5435-42
– reference: 18326618 - Am J Clin Nutr. 2008 Mar;87(3):778-84
– reference: 16008116 - Phytomedicine. 2005 Jun;12(6-7):410-5
– reference: 22935345 - Nutr Res. 2012 Aug;32(8):617-25
– reference: 16936160 - Diabetes Care. 2006 Sep;29(9):2102-7
– reference: 18029481 - J Nutr. 2007 Dec;137(12):2668-73
– reference: 17112576 - Cell. 2006 Dec 15;127(6):1109-22
– reference: 19202275 - Biosci Biotechnol Biochem. 2009 Feb;73(2):434-6
– reference: 17938737 - Environ Health Perspect. 2007 Oct;115(10):1467-73
– reference: 22191384 - Climacteric. 2012 Dec;15(6):611-20
– reference: 16449343 - J Clin Endocrinol Metab. 2006 Apr;91(4):1462-9
– reference: - Int J Obes (Lond). 2014 May;38(5):752
– reference: 23193181 - Diabetes. 2013 Apr;62(4):1186-95
– reference: 22436213 - Aging (Albany NY). 2012 Mar;4(3):146-58
– reference: 23418416 - PLoS One. 2013;8(2):e51648
– reference: 10584049 - Am J Clin Nutr. 1999 Dec;70(6):1040-5
– reference: 15394301 - J Physiol. 1949 Aug;109(1-2):1-9
– reference: 19207879 - Obes Rev. 2009 Mar;10(2):178-93
– reference: 9390982 - J Appl Physiol (1985). 1997 Dec;83(6):2064-72
– reference: 20725062 - Obesity (Silver Spring). 2011 Feb;19(2):298-304
– reference: 21455758 - J Physiol Biochem. 2011 Sep;67(3):471-7
– reference: 11282281 - J Steroid Biochem Mol Biol. 2000 Dec 31;75(4-5):265-71
– reference: 19967050 - Korean J Physiol Pharmacol. 2008 Aug;12(4):155-64
– reference: 15735366 - Ann Nutr Metab. 2005 Jan-Feb;49(1):33-41
– reference: 15738931 - Int J Obes (Lond). 2005 Jun;29(6):615-23
– reference: 11994393 - J Clin Endocrinol Metab. 2002 May;87(5):2391-4
– reference: 11333990 - N Engl J Med. 2001 May 3;344(18):1343-50
– reference: 23102619 - Cell Metab. 2012 Nov 7;16(5):658-64
– reference: 11679433 - Diabetes. 2001 Nov;50(11):2548-54
– reference: 18037457 - Physiol Behav. 2008 May 23;94(2):206-18
– reference: 22139637 - Genes Nutr. 2012 Jul;7(3):369-86
– reference: 17086191 - Nature. 2006 Nov 16;444(7117):337-42
– reference: 19026935 - Endocrinol Metab Clin North Am. 2008 Dec;37(4):841-56
– reference: 18445174 - Diabet Med. 2008 May;25(5):597-605
– reference: 19942861 - Am J Hypertens. 2010 Feb;23 (2):192-6
– reference: 17906192 - J Am Coll Nutr. 2007 Aug;26(4):389S-395S
– reference: 23855469 - Ann N Y Acad Sci. 2013 Jul;1290:83-9
– reference: 20372175 - Eur J Clin Nutr. 2010 Jul;64(7):704-13
– reference: 21439945 - Biochem Pharmacol. 2011 Jun 1;81(11):1343-51
– reference: 23140132 - J Med Food. 2013 Feb;16(2):120-7
– reference: 6618956 - J Appl Physiol Respir Environ Exerc Physiol. 1983 Aug;55(2):628-34
– reference: 23855468 - Ann N Y Acad Sci. 2013 Jul;1290:74-82
– reference: 20573749 - Diabetes. 2010 Sep;59(9):2117-25
– reference: 16176615 - Br J Nutr. 2005 Sep;94(3):432-6
– reference: 22055504 - Cell Metab. 2011 Nov 2;14 (5):612-22
– reference: 20923528 - J Diabetes. 2009 Dec;1(4):278-87
– reference: 22497970 - Diabetes Res Clin Pract. 2012 Sep;97(3):474-82
– reference: 15970440 - J Steroid Biochem Mol Biol. 2005 Aug;96(3-4):301-7
– reference: 15563575 - Am J Physiol Regul Integr Comp Physiol. 2005 Mar;288(3):R708-15
SSID ssj0005502
ssj0033214
Score 2.368965
Snippet Background and Objectives: Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent...
Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent evidence has indicated that...
BACKGROUND AND OBJECTIVES: Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent...
International Journal of Obesity (2014) 38, 698-706; doi:10.1038/ijo.2013.231
Background and Objectives:Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent...
Background and Objectives: Impaired regulation of lipid oxidation (metabolic inflexibility) is associated with obesity and type 2 diabetes mellitus. Recent...
SourceID proquest
gale
pubmed
pascalfrancis
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 698
SubjectTerms 631/443/319
692/699/2743/393
692/700/459/1994
Adult
Antioxidants - therapeutic use
Bioenergetics
Biological and medical sciences
Body fat
Body Mass Index
Body size
Body weight
Calorimetry
Catechin - analogs & derivatives
Catechin - therapeutic use
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Dietary Supplements
Double-Blind Method
Double-blind studies
Drug Therapy, Combination
Energy
Energy expenditure
Energy metabolism
Energy Metabolism - drug effects
Epidemiology
Fasting
Fatty acids
Female
Flexibility
Glucose
Glycerol
Health aspects
Health Promotion and Disease Prevention
Humans
Insulin resistance
Internal Medicine
Isoflavones
Lifestyles
Lipid Metabolism - drug effects
Lipid peroxidation
Lipids
Male
Medical sciences
Medicine
Medicine & Public Health
Metabolic Diseases
Metabolism
Metabolites
Middle Aged
Mitochondria
Musculoskeletal system
Obesity
original-article
Overweight
Overweight - diet therapy
Overweight - metabolism
Overweight persons
Oxidation
Oxidation-Reduction
Physiological aspects
Physiological research
Polyphenols
Polyphenols - therapeutic use
Postprandial Period
Public Health
Quotients
Respiratory quotient
Resveratrol
Stilbenes - therapeutic use
Substrates
Toxicology
Treatment Outcome
Womens health
Title Short-term supplementation with a specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects
URI https://link.springer.com/article/10.1038/ijo.2013.231
https://www.ncbi.nlm.nih.gov/pubmed/24317366
https://www.proquest.com/docview/1520967002
https://www.proquest.com/docview/2639125352
https://www.proquest.com/docview/1521913107
https://www.proquest.com/docview/1837323808
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgkxDShKB8BUYxEowHlK2x8-E8oTE2TUirEDCpb5HtOKIoS7q6fdifw3_KneO0VJS9VJV8iR37fP6d74uQt1KUKpV5EjLQcsI44yrMZWlCpvJKi0Ro7TLwXYzT88v4yySZ-As3690qe5noBHXZarwjP4rQXwNjStjH2XWIVaPQuupLaNwlu5i6DF26skm2dvFIRqtcUhwr8vRZEeHUT7wX_IiLo-kvDAOM-CHj0cb55KX03kxamLGqK3WxDYv-Y0d1x9PZQ_LA40p63DHCI3LHNAMSfJ6aBT2gPvlnTcd97v0BuXfhreoDMlhjRyB2dc_tY_L7-0_4E6LophZrf3Z-5o4Kb2-ppBimia5GFKYQNOyura1oCd3K-Q2dtfUN-pC1taXTBvuwxlLjwg0p1hZAe_lybqhsSurs9ha6Ui6Vr6FX8BLV1lN7BQ_T1nlw41UCkuDtkX1CLs9Of5ych76gQ6iTOF2EXAsTVVEuozip4Hw0uVQAR2TES5OOjGYq4ZIb5mDZSMq4YqzSPAYlVecqV_wp2WnaxjwnVImUMwW6pZCgQAqjYuVSGWbAW4plJiAf-mUstM92jkU36sJZ3bkoYNELXPQCFj0g71bUsy7Lx3_oXiNHFF2M6ko4FMc8FSIWSR4H5L2jQPEA_Wnpoxxg1Jhoa4Nyf4MStrXeaB5ucN1qXAwNxcDN8HzPhoWXO7ZY75KtzQzwKCBaAN0BebNqxp7R1a4x7dK9AnR4QP3ZLTSCZxzA3kgE5Fm3A9bjQ0jK0zQgB_2W-Gt8Wyb1xe0f8pLcB8q4czLdJzuL-dK8AiC4UEO32-FXnERDsvvpdPz12x9I_V37
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw8DQ6CZAQgvIVGJuR2HhAYY2dpM4DQoNt6thWIdikvQU7cURRl5SmFerP4Q_wG7lzkpaKsre9VfLZ5_TO5zvfF8BLJVMdqihwOVo5rt8V2o1UalyuoyyRgUwSW4HvtB_2zv2PF8HFGvxucmEorLKRiVZQp0VCb-S7HsVrUE4Jfzf64VLXKPKuNi00KrY4NrOfaLKVb4_2kb7bnB8enH3ouXVXATcJ_HDiikQaL_Mi5flBhkLaRErjnag8kZqwYxKuA6GE4VY36CjlZ5xnifDRUkoiHWmB696AdV-gKdOC9fcH_U-fF0ElQWdevUpQD6CmDiOuFdRx9x0hdwffKfHQE2-48JZuxPpeuDNSJdIoq5prrNJ-__Hc2gvx8B7crTVZtlex3n1YM3kbnP2BmbAdVpcbHbJ-U-2_DTdPaz9-G9oLbRWBbaf18gH8-vINf7h0WbCSuo1Wke0Wit6LmWKUGErBTQyJhjZ9NVZkLEW0ajxjo2I4o6i1YliyQU44SlMyYxMcGXUzIA_9dGyYylNmIwVKRKVt8WDDLnERXQwH5SVOZoWNGafHCwKh96ryIZxfC7EfQSsvcvMEmJah4BqtWanQZJVG-9oWT-wiN2veNQ68bsgYJ3V9dWrzMYytn1_IGIkeE9FjJLoD23PoUVVX5D9wW8QRcZUVOxdH8Z4IpfRlEPkOvLIQJJAQX6LqvArcNZX2WoLcWIJEQZIsDW8ucd18X5xc08jNOL9hw7iWdGW8OJcrhzlqwKhDo5rvwIv5MGGm4L7cFFO7hBd5aGd0r4CRoitQvexIBx5XJ2CxP1KCRRg6sNMcib_2t-JPfXr1h2zBrd7Z6Ul8ctQ_fga3cZZfhbhuQGsynprnqIZO9GZ99hl8vW5x8wf-_5kz
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkCYkhKB8BcZmJDYeUGhj58N5QGiiVBtjFRJM2luwHUcUdUmpW6H-Ofwb_HXcOUlLRdnb3ir5_JHe-Xxn_-6OkBdS5CqWaeQz8HL8MOHKT2VufKbSQotIaO0y8J0N4-Pz8MNFdLFFfrexMAirbHWiU9R5pfGOvBsgXgNjSli3aGARn_qDt5MfPlaQwpfWtpxGLSKnZvET3Df75qQPvD5gbPD-y7tjv6kw4OsojGc-18IERZDKIIwKUNgmlQrORxnw3MQ9o5mKuOSGOTuhJ2VYMFZoHoLXpFOVKg7j3iA3Ex4FuMeSi2QFL4l6yzxWHKsBtRkZYaSoQeD3uOiOvmMIYsBfMx6snY3NCXF7Ii1wq6jLbGyyg_95w3VH4-AuudPYtPSoFsJ7ZMuUHeL1R2ZGD2mTeHRMh23e_w7ZOWte9Duks7JbgdjVXLf3ya_P3-CHj8cGtVh3tMa4Oyq8OaaSYogowpwosA-8-7qtKmgO08rpgk6q8QLxa9XY0lGJc1hjqXGhjhTrGuBb_XxqqCxz6jADFqZSLo2woZcwiKrGI3sJnWnl0ON4jYEkeHNlH5Dza2H1Q7JdVqV5TKgSMWcK_FohwXkVRoXKpVFMQK4VS4xHXrVszHSTaR0Lfowz9-LPRQZMz5DpGTDdIwdL6kmdYeQ_dPsoEVkdH7tUTNkRj4UIRZSGHnnpKFA1wXxaNhEWsGpM8rVGubtGCSpFrzXvrUndcl0MH6lBmqF_K4ZZo_NsttqhG5sZ2MJgTYPB75Hny2acGWF-panmboggDcDjSK6gETzhYGj2hEce1TtgtT40h3kce-Sw3RJ_rW_Dn_rk6g_ZJzugZLKPJ8PTp-QWdAprrOsu2Z5N5-YZ2KMztec2PiVfr1vT_AFt3pwD
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Short-term+supplementation+with+a+specific+combination+of+dietary+polyphenols+increases+energy+expenditure+and+alters+substrate+metabolism+in+overweight+subjects&rft.jtitle=International+Journal+of+Obesity&rft.au=Most%2C+J&rft.au=Goossens%2C+G+H&rft.au=Jocken%2C+J+W+E&rft.au=Blaak%2C+E+E&rft.date=2014-05-01&rft.issn=0307-0565&rft.volume=38&rft.issue=5&rft.spage=698&rft.epage=706&rft_id=info:doi/10.1038%2Fijo.2013.231&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0307-0565&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0307-0565&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0307-0565&client=summon